| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | ColdSnap | Foodtech Food Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $104.36M | Series F | 4/2/2026 | $21.64M | $109.63M | $3.95 | Undisclosed Investors | ||||
 | ConductorOne | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110.72M | Series B | 10/28/2025 | $65M | $350M | $13.20 | Greycroft, CrowdStrike, Accel, Felicis, Oregon Venture Fund, Operator Collective | ||||
 | CoRegen | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $131.81M | Series B-1 | 10/28/2025 | $13.5M | $431.58M | $18.00 | Undisclosed Investors | ||||
 | Courier Health | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $70.45M | Series B-1 | 4/22/2026 | $45.97M | $264.59M | $21.50 | Oak HC/FT, Norwest, Work-Bench | ||||
 | Crossnokaye | Foodtech Other Foodtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $88.45M | Series C | 4/8/2025 | $39.45M | $284.12M | $1.00 | Koch Disruptive Technologies | ||||
 | Culture | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $142.12M | Series C-2 | 12/16/2025 | $20.52M | $60.79M | $0.29 | Northpond Ventures, Synthesis Capital, S32, Cultivian Sandbox | ||||
 | Curbio | Real Estate Real Estate Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $5M | Series Seed-1 | 10/31/2025 | $5M | $7.43M | $0.03 | Undisclosed Investors | ||||
 | Daloopa | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $105.91M | Nonvoting Series C | 8/19/2026 | $3M | $326.42M | $6.46 | Undisclosed Investors | ||||
 | Daring Foods | Foodtech Animal-Free Protein | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $105.73M | Series C | 10/27/2021 | $53M | $328.62M | $12.96 | Founders Fund, D1 Capital Group, Naomi Osaka, Cameron Newton, Steve Aoki, Chase Coleman | ||||
 | DataXu | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $92.85M | Series F | 1/25/2016 | $10M | $382.38M | $1.99 | Sky | ||||
 | Dewpoint | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $354.6M | Series D | 9/10/2025 | $59.12M | $136.62M | $0.23 | 120 Capital | ||||
 | DexCare | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $161M | Series D | 8/28/2026 | $16M | $446.46M | $2.30 | Undisclosed Investors | ||||
 | Dstillery | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $65.9M | Series 2A | 4/17/2026 | $8.2M | $236.6M | $1.69 | Undisclosed Investors | ||||
 | Elucid Bioimaging | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $156.63M | Series D | 10/10/2025 | $36.5M | $316.49M | $2.13 | Undisclosed Investors | ||||
 | Engrail Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $215.08M | Series B-4 | 4/7/2025 | $10M | $275.98M | $1.06 | Undisclosed Investors | ||||
 | Enko Chem | Industrial Other Industrial | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $150.66M | Series C | 7/27/2022 | $80M | $338.64M | $4.86 | Nufarm, Anterra Capital, Taher Gozal, Bill & Melinda Gates Foundation, Eight Roads Ventures, Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, Endeavor8, Alumni Ventures Group, Rabo Food & Agri Innovation Fund | ||||
 | Enya | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $2.89M | Series Seed | 1/1/2020 | $2.89M | $15.54M | $1.57 | First Rays Venture Partners, XSeed Capital, Morado Venture Partners, 2.12 Angels, AiiM Partners | ||||
 | Eureka Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $130.85M | Series E | 12/16/2019 | $45M | $359.7M | $4.16 | Lyell Immunopharma, Acorn Pacific Ventures, GP Capital, Suma Venture, Harbinger Venture Capital, Yuan Capital, Majuven | ||||
 | Exactera | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $119.65M | Series A | 7/17/2023 | $119.65M | $143.97M | $3.86 | Kennet Partners, Insight Venture Partners, Savant Growth Partners | ||||
 | FINESSE | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $56.38M | Series A-1 | 7/1/2023 | $40M | $300.43M | $17.12 | TQ Ventures, Cherry Ventures, MaC Venture Capital, Hoxton Ventures, Mango Capital | ||||
 | Flagler Health | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $62.75M | Series B | 8/11/2026 | $50M | $238.83M | $10.39 | Bessemer Venture Partners, SignalFire, Alumni Ventures, Streamlined, 186 Ventures, PROOF, Tribeca Venture Partners, Offscript | ||||
 | Flare Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $290.35M | Series C | 6/30/2026 | $85M | $188.49M | $0.37 | Third Rock Ventures, Nextech Invest, Pfizer, Boxer Capital, GordonMD Global Investments, Invus, Casdin Capital, Eli Lilly and Company, Novartis, Agent Capital, Eventide Asset Management | ||||
 | Flyhomes | Real Estate Real Estate Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $208.35M | Series D | 7/30/2025 | $15M | $112.29M | $0.38 | Andreessen Horowitz, Norwest, Canvas Prime, Camber Creek, Al Goldstein, Mark Vadon | ||||
 | Fortem Technologies | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $103.63M | Series B | 4/22/2026 | $21.39M | $300.4M | $2.32 | Lockheed Martin | ||||